NO20070986L - Antiblodplate middel og fremgangsmate for fremstilling derav - Google Patents

Antiblodplate middel og fremgangsmate for fremstilling derav

Info

Publication number
NO20070986L
NO20070986L NO20070986A NO20070986A NO20070986L NO 20070986 L NO20070986 L NO 20070986L NO 20070986 A NO20070986 A NO 20070986A NO 20070986 A NO20070986 A NO 20070986A NO 20070986 L NO20070986 L NO 20070986L
Authority
NO
Norway
Prior art keywords
preparation
plate agent
antibody plate
compound
antibody
Prior art date
Application number
NO20070986A
Other languages
English (en)
Norwegian (no)
Inventor
Kenji Sakuratani
Koji Sato
Syouko Yoshida
Tsutomu Yagi
Original Assignee
Daiichi Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Seiyaku Co filed Critical Daiichi Seiyaku Co
Publication of NO20070986L publication Critical patent/NO20070986L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A61K31/501—Pyridazines; Hydrogenated pyridazines not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO20070986A 2004-08-06 2007-02-21 Antiblodplate middel og fremgangsmate for fremstilling derav NO20070986L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2004230011 2004-08-06
PCT/JP2005/014405 WO2006013962A1 (ja) 2004-08-06 2005-08-05 抗血小板薬およびその製造方法

Publications (1)

Publication Number Publication Date
NO20070986L true NO20070986L (no) 2007-04-20

Family

ID=35787240

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20070986A NO20070986L (no) 2004-08-06 2007-02-21 Antiblodplate middel og fremgangsmate for fremstilling derav

Country Status (12)

Country Link
US (1) US20090137600A1 (ko)
EP (1) EP1775293A4 (ko)
JP (1) JPWO2006013962A1 (ko)
KR (1) KR20070046099A (ko)
CN (1) CN101072769A (ko)
AU (1) AU2005268058A1 (ko)
CA (1) CA2574626A1 (ko)
IL (1) IL180988A0 (ko)
MX (1) MX2007001566A (ko)
NO (1) NO20070986L (ko)
RU (1) RU2007108297A (ko)
WO (1) WO2006013962A1 (ko)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102924476A (zh) * 2009-02-09 2013-02-13 沈阳药科大学 新噁嗪类化合物及其用途
CN101486714B (zh) * 2009-02-09 2013-03-20 沈阳药科大学 新噁嗪类化合物及其抗血小板聚集的用途
CN101486713B (zh) * 2009-02-09 2013-05-15 沈阳药科大学 呋喃并[2,3-h]色烯类化合物及其抗血小板聚集的用途
KR20120027265A (ko) * 2009-04-27 2012-03-21 다우 아그로사이언시즈 엘엘씨 살충성 피리딘 화합물

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH27357A (en) * 1989-09-22 1993-06-21 Fujisawa Pharmaceutical Co Pyrazole derivatives and pharmaceutical compositions comprising the same
FR2692575B1 (fr) * 1992-06-23 1995-06-30 Sanofi Elf Nouveaux derives du pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant.
JP3994453B2 (ja) * 1995-10-13 2007-10-17 日産化学工業株式会社 ピラゾロン類
US7087630B2 (en) * 2002-06-27 2006-08-08 Nitromed, Inc. Cyclooxygenase 2 selective inhibitors, compositions and methods of use
PL377778A1 (pl) * 2002-12-02 2006-02-20 Astellas Pharma Inc. Pochodne pirazolu
CA2515119A1 (en) * 2003-02-07 2004-08-19 Daiichi Pharmaceutical Co., Ltd. Pyrazole derivative
US20060189591A1 (en) * 2003-04-21 2006-08-24 Daiichi Pharmaceutical Co., Ltd. Five-membered heterocyclic derivative

Also Published As

Publication number Publication date
AU2005268058A1 (en) 2006-02-09
IL180988A0 (en) 2007-07-04
EP1775293A1 (en) 2007-04-18
EP1775293A4 (en) 2009-09-16
CA2574626A1 (en) 2006-02-09
US20090137600A1 (en) 2009-05-28
WO2006013962A1 (ja) 2006-02-09
MX2007001566A (es) 2007-04-16
KR20070046099A (ko) 2007-05-02
RU2007108297A (ru) 2008-09-20
JPWO2006013962A1 (ja) 2008-05-01
CN101072769A (zh) 2007-11-14

Similar Documents

Publication Publication Date Title
WO2006072393A3 (de) Sulfonylpyrrolidine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
EA200601584A1 (ru) Замещённые глюкопиранозилом бензольные производные, содержащие эти соединения лекарственные средства, их применение и способ их получения
EA200801608A1 (ru) Производные бензимидазолонкарбоновой кислоты
NO20080761L (no) Acykliske Ikur inhibitorer
WO2005074642A3 (en) Chemical compounds
NO20070751L (no) Inhibitorer av HCV-replifikasjon
NO20063479L (no) Fosfonater, monofosfonamidater og bis-fosfonamidater for behandling av virussykdommer
NO20080784L (no) Histondeacetylaseinhibitorer
NO20063576L (no) 1,3-dioksanederivativer og analoge forbindelser for behandling av fedme og diabetes
NO20090628L (no) Pyridizinon derivativater
NO20053892L (no) Virale polymeraseinhibitorer
CY1113011T1 (el) Νεα κρυσταλλικη μορφη v της αγομελατινης, μεθοδος παρασκευης αυτης και φαρμακευτικες συνθεσεις που περιεχουν αυτην
NO20080865L (no) Spirokromanonderivater som acetyl-koenzym-A-karboksylase(ACC)inhibitorer
NO20082209L (no) Homo- og heterocykliske forbindelser anvendbare som CETP-inhibitorer
EA200702346A1 (ru) КРИСТАЛЛИЧЕСКАЯ ФОРМА 1-ХЛОР-4-(β-D-ГЛЮКОПИРАНОЗ-1-ИЛ)-2-[4-((S)-ТЕТРАГИДРОФУРАН-3-ИЛОКСИ)БЕНЗИЛ]БЕНЗОЛА, СПОСОБ ЕЁ ПОЛУЧЕНИЯ И ЕЁ ПРИМЕНЕНИЕ ДЛЯ ПРИГОТОВЛЕНИЯ ЛЕКАРСТВЕННЫХ СРЕДСТВ
AR051754A1 (es) Metodos para preparar compuestos de indazol
EA201070186A1 (ru) Способы и соединения, предназначенные для получения ингибиторов котранспортера натрий-глюкозы 2 типа
NO20072963L (no) 5-substituerte kinolin- og isokinolinderivater, fremgangsmate for deres fremstilling og deres anvendelse som betennelseshemmere
NO20062021L (no) Omleirede pentanoler, fremgangsmpte for fremstilling av dette, og deres anvendelse som antiflogistika
NO20075706L (no) Pyrrolopyridinbaserte inhibitorer av dipeptidylpeptidase IV og metoder
TW200633981A (en) Process for the preparation of a 2-ethylaminopyridine derivative
AU2006232435A8 (en) BCRP/ABCG2 inhibitor
NO20076145L (no) Ureadeviater, fremgangsmater for deres fremstilling og anvendelse derav
NO20064351L (no) Caspaseinhibitorer og anvendelser derav
NO20071254L (no) Fremgangsmate for fremstilling av irbesartan og mellomprodukter derav.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application